Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Felix Lerintiu"'
Publikováno v:
Polish Journal of Pathology, Vol 75, Iss 1, Pp 61-62 (2024)
Externí odkaz:
https://doaj.org/article/cffd8b135b64494e8b1a743c71d76fad
Autor:
Antoine Ittel, Eric Jeandidier, Catherine Helias, Nathalie Perrusson, Catherine Humbrecht, Bruno Lioure, Isabelle Mazurier, Caroline Mayeur-Rousse, Amandine Lavaux, Sylvie Thiebault, Felix Lerintiu, Carine Gervais, Laurent Mauvieux
Publikováno v:
Haematologica, Vol 98, Iss 12 (2013)
Externí odkaz:
https://doaj.org/article/8dead5faf6214b2ca6a7c5c605ab21d7
Autor:
Agusti Alentorn, Isaias Hernández-Verdin, Eva Kirasic, Kirsty Wienand, Sandrine Eimer, Hugues Loiseau, Audrey Rousseau, Jérôme Paillassa, Guido Ahle, Felix Lerintiu, Emmanuelle Uro-Coste, Lucie Oberic, Dominique Figarella-Branger, Olivier Chinot, Guillaume Gauchotte, Luc Taillandier, Jean-Pierre Marolleau, Marc Polivka, Clovis Adam, Renata Ursu, Anna Schimitt, Noemie Barillot, Lucia Nichelli, Fernando Lozano-Sánchez, Maria-José Ibañez-Juliá, Matthieu Peyre, Bertrand Mathon, Yah-se Abada, Frederic Charlotte, Frédéric Davi, Chip Stewart, Aurélien de Reyniès, Sylvain Choquet, Carole Soussain, Caroline Houillier, Bjoern Chapuy, Khe Hoang-Xuan
Primary central nervous system lymphoma (PCNSL) is a distinct extranodal lymphoma presenting with limited stage disease but variable response rates to treatment despite homogenous pathological presentation. The likely underlying molecular heterogenei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a906a05dad06be48c44d736b6668616
https://doi.org/10.21203/rs.3.rs-1438980/v1
https://doi.org/10.21203/rs.3.rs-1438980/v1
Autor:
Bernard Goichot, Felix Lerintiu, Agnes Smagala, Philippe Keller, Niculina Racolta, Sarah Homsi, V Linder
Publikováno v:
Endocrine Abstracts.
Autor:
Felix Lerintiu, Maxime Maurer, Jimmy Voirin, Guido Ahle, Bernard Drenou, Agathe Debliquis, Inès Harzallah
Publikováno v:
Cytometry Part B: Clinical Cytometry. 94:182-188
Background Central nervous system lymphomas are aggressive tumors requiring a prompt diagnosis for successful treatment. Stereotactic biopsy remains the standard procedure, but the time needed for histopathology is usually over 2 days. We evaluated t
Autor:
Agathe, Debliquis, Jimmy, Voirin, Inès, Harzallah, Maxime, Maurer, Felix, Lerintiu, Bernard, Drénou, Guido, Ahle
Publikováno v:
Cytometry. Part B, Clinical cytometry. 94(1)
Central nervous system lymphomas are aggressive tumors requiring a prompt diagnosis for successful treatment. Stereotactic biopsy remains the standard procedure, but the time needed for histopathology is usually over 2 days. We evaluated the contribu
Autor:
Amandine Lavaux, Laurent Mauvieux, Bruno Lioure, Catherine Helias, Felix Lerintiu, Antoine Ittel, Caroline Mayeur-Rousse, Carine Gervais, Eric Jeandidier, Sylvie Thiebault, Isabelle Mazurier, N Perrusson, Catherine Humbrecht
Publikováno v:
Haematologica. 98:e166-e168
In the April 2013 issue of Haematologica, Lee et al. have described the TET1 genomic breakpoints and clinical features of MLL-TET1 rearranged cases of acute leukemia.[1][1] So far, 13 cases have been reported in the literature, 11 in acute myeloid le
Autor:
Inès Harzallah, Jimmy Voirin, Maxime Maurer, Agathe Debliquis, Guido Ahle, Bernard Drenou, Felix Lerintiu
Publikováno v:
Revue Neurologique. 171:A122-A123
Introduction Le lymphome cerebral est une urgence diagnostique et therapeutique. En dehors d’une meningite lymphomateuse, le diagnostic histologique apres biopsie stereotaxique est rendu apres 48 ou 72 heures. Objectifs Etude de faisabilite de l’
Autor:
Laurent Mauvieux, Catherine Humbrecht, Carine Gervais, N Perrusson, Catherine Helias, Isabelle Mazurier, Caroline Mayeur-Rousse, Felix Lerintiu, Eric Jeandidier, Antoine Ittel, Sylvie Thiebault, Bruno Lioure
Publikováno v:
Blood. 122:1357-1357
TET1 genomic breakpoints and clinical features of MLL-TET1 rearrangements have been described in 13 acute leukemia cases, 11 in AML, 2 in B cell-precursor ALL. The incidence of this rare translocation was evaluated to 0.3% of MLL rearranged AML cases